Alto Ingredients, Inc.
NASDAQ:ALTOChemicals - Specialty
-$0.07 today
- Market cap
- $257.92M
- Beta
- 0.14
- P/E (TTM)
- 12.5
- EPS (TTM)
- $0.39
Volume 1.03M
Average 1.92M
ALTO Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Alto Ingredients, Inc.NASDAQ: ALTO
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns positive
Q1 FY2026 net income was $3.96M, compared with -$11.68M a year earlier. Trailing-twelve-month net income was $28.98M.
Context
- Net income amounted to 1.5% of revenue in FY2025, down 4.7 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of $35.94M (+169.4%) for the fiscal year ending Dec 2026, a step up from the +122.6% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $3.96M-81.8% QoQ
- Last fiscal yearDec 2025
- $13.34M+122.6% YoY
- LTMMar 2026
- $28.98M+149.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +133.9% | +159.2% | +25.3 pp |
| 1 year | +122.6% | +169.4% | +46.8 pp |
| 3-year CAGR | — | +41.6% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 13.34M USD
- Year-over-year change
- +122.6%
- 4-year CAGR
- -26.7%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 13.34M | +122.6% |
| FY2024 | 2024-12-31 | (58.98M) | -110.6% |
| FY2023 | 2023-12-31 | (28.01M) | +32.7% |
| FY2022 | 2022-12-31 | (41.6M) | -190.3% |
| FY2021 | 2021-12-31 | 46.08M | — |
Net Income vs competitors
How ALTO compares with its peers on the latest reported figures
- ALTO's LTM Mar 2026 net income of $28.98M is the 6th largest of the 7 companies compared; the peer median is $24.77M.
- Its year-over-year change of +149.2% is the 2nd highest of 7, against a peer median of -18.6%.
- Net income amounts to 3.2% of revenue for ALTO, versus a peer median of 17.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $350M | -21.7% | +25.3% | 6.8% | |
| LTM Apr 2026 | $102.85M | +42.9% | +35.8% | 15.7% | |
| LTM Mar 2026 | $74.19M | -15.5% | -10.6% | 33.8% | |
| LTM Mar 2026 | $52.34M | +708.9% | — | 47.5% | |
| LTM Mar 2026 | $33.17M | -59.3% | -30.7% | 19.0% | |
| LTM Mar 2026 | $28.98M | +149.2% | — | 3.2% | |
| LTM Mar 2026 | $16.38M | -84.2% | +5.5% | 0.8% | |
| Peer median (excluding ALTO) | $24.77M | -18.6% | +5.5% | 17.3% | |
Competitors are the stored peer set for ALTO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 46.08M | (41.6M) | (28.01M) | (58.98M) | 13.34M |
| Depreciation & Amortization | 23.29M | 25.1M | 23.08M | 24.41M | 25.22M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.88M | 3.33M | 3.9M | 4.36M | 3.02M |
| Change in Working Capital | (13.19M) | 31.55M | 3.71M | 9.96M | (16.44M) |
| Accounts Receivables | (43.55M) | 23.97M | 9.5M | 562K | 3.31M |
| Inventory | (16.45M) | (15.48M) | 11.82M | 4.48M | (12.62M) |
| Accounts Payables | 0 | 28.12B | (12.55M) | 9.95M | (2.83M) |
| Other Working Capital | 46.81M | (28.09B) | (5.05M) | (5.03M) | (4.31M) |
| Other Non-Cash Items | (32.24M) | (12.34M) | 19.35M | 16.74M | (11.89M) |
| Operating Cash Flow | 26.82M | 6.05M | 22.03M | (3.52M) | 13.25M |
| Capital Expenditures | (16.38M) | (37.74M) | (29.53M) | (11.07M) | (4.6M) |
| Acquisitions (Net) | 43.5M | (14.69M) | (3.5M) | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 14.77M | 0 | (2.4M) | (2.83M) |
| Investing Cash Flow | 27.12M | (37.66M) | (33.03M) | (13.47M) | (7.43M) |
| Debt Repayment | (37.61M) | 26.78M | 12.61M | 8.99M | (15.09M) |
| Common Stock Issued | 462K | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (1.33M) | (3.67M) | 0 | 0 |
| Dividends Paid | (2.85M) | (1.27M) | (1.27M) | (1.27M) | (1.27M) |
| Other Financing Activities | 0 | (5.17M) | (714K) | 0 | 0 |
| Financing Cash Flow | (40M) | 19.01M | 6.96M | 7.72M | (16.36M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 13.94M | (12.6M) | (4.05M) | (9.27M) | (10.54M) |
| Free Cash Flow | 10.44M | (31.7M) | (7.51M) | (14.59M) | 8.65M |
Alto Ingredients, Inc.
NASDAQ:ALTO
Intrinsic Alpha fair value
Locked
Current Price
$3.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.